Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-06-04

Clinical Trial Update: Evaluation of the Effect of a Nasal Allergen Challenge With Dermatophagoides Farinae Extract on Nasal Airway Inflammation in Allergic Individuals, Comparing E-cigarette Users to Cigarette Smokers and Non-smokers. [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating nasal allergen challenge effects on nasal inflammation comparing E-cigarette users, cigarette smokers, and non-smokers; terminated with…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of North Carolina, Chapel Hill | Conditions: Healthy Participants, Tobacco Smokers | Phase 1 | Status: TERMINATED | Results posted: 2021-06-04